Ovid Therapeutics OVID Q1 2026 earnings

FAQ

When did Ovid Therapeutics report Q1 2026 earnings?

Ovid Therapeutics (OVID) reported Q1 2026 earnings on May 12, 2026 before market open.

What were Ovid Therapeutics's Q1 2026 revenue and EPS?

Ovid Therapeutics reported eps of $-0.12 for Q1 2026.

Did Ovid Therapeutics beat estimates in Q1 2026?

EPS beat the consensus estimate of $-0.12 by $0.00.

How did Ovid Therapeutics's Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 14.3% from $-0.14.

Where can I find Ovid Therapeutics's Q1 2026 SEC filings?

You can read the 8-K earnings release (0001628280-26-033859) and the 10-Q periodic report (0001628280-26-033864) directly on SEC EDGAR. The filing index links above go to sec.gov.